Deciphering Intracellular Signaling Pathways in Tumoral Pathologies

Area of Science:

• Biomedical research
• Oncology
• Molecular biology

Background:

• Cancer's heterogeneity necessitates advanced screening for comprehensive tumor characterization.
• Biomarkers derived from high-throughput screening are crucial for cancer prediction, prognosis, and therapeutic target identification.
• Microarray technology offers rapid, exhaustive analysis of diverse biological samples, making it vital in biomedical research.

Purpose of the Study:

• To describe the operational process of protein microarrays utilizing antibody-antigen interactions.
• To highlight the application of protein microarrays in analyzing intracellular signaling pathways in tumoral pathologies.
• To validate microarray findings using nucleic acid programmable protein array (NAPPA) technology and ELISA assays for functional protein characterization.

Main Methods:

• Protein microarray construction based on antibody-antigen interactions.
• Analysis of intracellular signaling pathways in tumor samples using microarrays.
• Validation of protein candidates through nucleic acid programmable protein array (NAPPA) and ELISA assays.

Main Results:

• Demonstrated the utility of protein microarrays for high-throughput screening of tumoral pathologies.
• Identified key proteins and signaling pathways implicated in cancer through microarray analysis.
• Successfully validated functional characteristics of proteins identified via microarray screening using NAPPA and ELISA.

Conclusions:

• Protein microarrays are effective tools for comprehensive biomarker discovery in heterogeneous diseases like cancer.
• Analysis of intracellular signaling pathways via microarrays provides insights into tumoral pathologies.
• NAPPA technology and ELISA assays serve as valuable methods for validating functional protein characterization from microarray data.